ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 359,89
0,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Microbot Medical Inc (MBOT)

  7. Microbot Medical Inc (MBOT) Actualités

MBOT

Microbot Medical (MBOT)

Microbot Medical Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MBOT
DateHeureSourceTitreSymboleSociété
04/06/202422h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
04/06/202422h20GlobeNewswire Inc.Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:MBOTMicrobot Medical Inc
04/06/202414h30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBOTMicrobot Medical Inc
03/06/202422h01Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MBOTMicrobot Medical Inc
03/06/202418h11GlobeNewswire Inc.Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:MBOTMicrobot Medical Inc
03/06/202414h20GlobeNewswire Inc.Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical TrialNASDAQ:MBOTMicrobot Medical Inc
16/05/202422h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
15/05/202414h45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MBOTMicrobot Medical Inc
29/04/202414h30GlobeNewswire Inc.Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™NASDAQ:MBOTMicrobot Medical Inc
15/04/202414h30GlobeNewswire Inc.Microbot Medical Shares Status Following Recent Geopolitical EventsNASDAQ:MBOTMicrobot Medical Inc
27/02/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
20/02/202422h35Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBOTMicrobot Medical Inc
14/02/202420h49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MBOTMicrobot Medical Inc
05/02/202413h30GlobeNewswire Inc.Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USNASDAQ:MBOTMicrobot Medical Inc
30/01/202413h20GlobeNewswire Inc.Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersNASDAQ:MBOTMicrobot Medical Inc
26/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBOTMicrobot Medical Inc
22/01/202423h20Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MBOTMicrobot Medical Inc
18/01/202413h20GlobeNewswire Inc.Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical StudyNASDAQ:MBOTMicrobot Medical Inc
29/12/202314h00GlobeNewswire Inc.Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq RulesNASDAQ:MBOTMicrobot Medical Inc
28/12/202313h30GlobeNewswire Inc.Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were MetNASDAQ:MBOTMicrobot Medical Inc
14/12/202314h15GlobeNewswire Inc.Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for TeleroboticNASDAQ:MBOTMicrobot Medical Inc
07/12/202314h00GlobeNewswire Inc.Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical StudyNASDAQ:MBOTMicrobot Medical Inc
01/12/202323h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
30/11/202322h31Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:MBOTMicrobot Medical Inc
21/11/202315h12GlobeNewswire Inc.Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial ActivitiesNASDAQ:MBOTMicrobot Medical Inc
17/11/202322h31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MBOTMicrobot Medical Inc
13/11/202314h30GlobeNewswire Inc.Microbot Medical Successfully Completed Integral Part of the Verification and Validation ProcessNASDAQ:MBOTMicrobot Medical Inc
08/11/202315h10GlobeNewswire Inc.Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark OfficeNASDAQ:MBOTMicrobot Medical Inc
31/10/202313h25GlobeNewswire Inc.Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical StudyNASDAQ:MBOTMicrobot Medical Inc
24/10/202314h19GlobeNewswire Inc.Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024NASDAQ:MBOTMicrobot Medical Inc
 Showing the most relevant articles for your search:NASDAQ:MBOT

Dernières Valeurs Consultées

ASX
OZLCD
Oz Minerals
BIT
P1UY24
NLBNPIT1UY24 20351219 14...
NASDAQ
SPKBW
Silver Spike Acquisition...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés